Pages that link to "Q37054982"

The following pages link to Relationship between circulating BAFF serum levels with proliferating markers in patients with multiple myeloma (Q37054982):

Displaying 8 items.

• B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia (Q26784444) (← links)
• Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma. (Q33437811) (← links)
• Neopterin and beta-2 microglobulin relations to immunity and inflammatory status in nonischemic dilated cardiomyopathy patients (Q34118314) (← links)
• B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy? (Q38365867) (← links)
• Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma. (Q45756098) (← links)
• Prognostic Value of IL-10 and Its Relationship with Disease Stage in Iranian Patients with Multiple Myeloma (Q49649026) (← links)
• Mast cells influence the proliferation rate of myeloma plasma cells. (Q53595339) (← links)
• Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma (Q86874224) (← links)